Search Autoimmune Association
Share this article
Us Capitol Building

Autoimmune Association Leads Sign-On Letter, 64 Patient Groups Ask Congress to Protect Rare Disease Drug Development

December 2021– In a letter sent December 14 to congressional leadership, 64 patient organizations signed on to the Autoimmune Association’s letter asking congress to remove a provision from the currently drafted text of the Build Back Better Act that would dramatically curtail the Orphan Drug Tax Credit for qualified clinical testing expenses by removing a critical incentive for all but the first approved orphan use of a new drug.

Over 90% of rare diseases lack an FDA-approved treatment indicated for the specific rare disease, and since 2016 alone, 23 secondary orphan drug indications have been FDA approved for rare autoimmune diseases. At such a promising time, Congress should be protecting and investing in the future of those without a current FDA approved treatment, rather than removing incentives for the development of future therapies for those who depend on it the most.  Click here to read the full letter.

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Advocates Take Action at the Autoimmune Association’s Legislative Fly-In

On Thursday, March 20, 2025, advocates from 16 states came together for the Autoimmune Association’s Annual Legislative Fly-In event. Sharing personal stories, these...
Autoimmune Association Image Do Not Touch

Autoimmune Association Continues to Advocate to Protect Copay Assistance and Essential Health Benefits

The Autoimmune Association has shared comments with the office of Health and Human Services (HHS) regarding the 2026 Notice of Benefit and Payment...
Autoimmune Association Image Do Not Touch

Autoimmune Association and Patient Advocacy Organizations Host Dr. Vicky Shanmugam, Director of the Office of Autoimmune Disease Research

The Autoimmune Association, along with partners in the autoimmune patient advocacy community, presented a luncheon last week in Washington, D.C. featuring Victoria Shanmugam,...
Autoimmune Association Image Do Not Touch

Important Medicare Part D Changes: What Autoimmune Patients Need to Know This Enrollment Period

As Medicare’s open enrollment period approaches, it’s important for patients living with autoimmune diseases to be aware of new changes to Medicare Part...

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.